Sunshine Biopharma Retains Renmark Financial Communications to Provide Investor Relations

MONTREAL, QC -- (Marketwired) -- 10/14/14 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused…

Continue Reading

Sunshine Biopharma–s Wholly Owned Canadian Subsidiary Completes the SOP–s Required by Health Canada to Secure Drug Establishment License

MONTREAL, QC -- (Marketwired) -- 10/01/14 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused…

Continue Reading

Sunshine Biopharma to Re-Domicile in Canada for Expansion and Financing Opportunities for Adva-27a Cancer Drug Candidate

MONTREAL, QC -- (Marketwired) -- 12/02/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused…

Continue Reading

Sunshine Biopharma Parent Company Acquires Garmen Laboratories, a Certified GMP Manufacturing Lab

MONTREAL -- (Marketwired) -- 08/26/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on…

Continue Reading

Sunshine Biopharma Parent Company Receives $510,000 Research Grant for Adva-27a Cancer Drug Candidate, Brings Total to $1.45 Million

MONTREAL and QUEBEC -- (Marketwired) -- 08/12/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company…

Continue Reading

Sunshine Biopharma Parent Company Awarded Research Grant of $940,000 to Advance Adva-27a Cancer Drug Candidate

MONTREAL -- (Marketwired) -- 07/16/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM) is pleased to announce that…

Continue Reading

Sunshine Biopharma Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells

MONTREAL -- (Marketwired) -- 06/04/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on…

Continue Reading

Sunshine Biopharma Narrows Kilogram Manufacturing Options for Adva-27a Breast Cancer Drug Candidate to Three Suppliers

MONTREAL -- (Marketwired) -- 05/01/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on…

Continue Reading

Sunshine Biopharma HMEC Study Indicates Novel Anticancer Compound Adva-27a Non-Toxic at High Concentrations

MONTREAL -- (Marketwired) -- 04/09/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on…

Continue Reading

Sunshine Biopharma Commences Negotiations With Contract Manufacturing Organizations for Production of Its Multidrug-Resistant Breast Cancer Drug, Adva-27a

MONTREAL -- (Marketwire) -- 03/14/13 -- Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on…

Continue Reading